Works matching IS 02683369 AND DT 1999 AND VI 23 AND IP 2

Results: 21

The cytotoxicity of mafosfamide on G-CSF mobilized hematopoietic progenitors is reduced by SH groups of albumin – implications for further purging strategies.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 157, doi. 10.1038/sj.bmt.1701541

By:

Schlenke, P;
Kisro, J;
Deeken, M;
Zajac, S;
Klich, S;
Wagner, T

Publication type:

Article

Bruno Speck.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 105, doi. 10.1038/sj.bmt.1701570

By:

Gordon-Smith, E C

Publication type:

Article

Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 111, doi. 10.1038/sj.bmt.1701536

By:

Stewart, D A;
Guo, D;
Morris, D;
Poon, M-C;
Ruether, B A;
Jones, A R;
Klassen, J;
Auer, I;
Luider, J;
Chaudhry, A;
Brown, C;
Russell, J A

Publication type:

Article

Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 151, doi. 10.1038/sj.bmt.1701537

By:

Wiesmann, A;
Weller, A;
Lischka, G;
Klingebiel, T;
Kanz, L;
Einsele, H

Publication type:

Article

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 107, doi. 10.1038/sj.bmt.1701540

By:

Grigg, A;
Bardy, P;
Byron, K;
Seymour, J F;
Szer, J

Publication type:

Article

Parentage testing implications of male fertility after allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 187, doi. 10.1038/sj.bmt.1701519

By:

Lipton, J H;
Marshall, W H;
Waye, J S

Publication type:

Article

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 145, doi. 10.1038/sj.bmt.1701529

By:

Michallet, M;
Perrin, M-C;
Belhabri, A;
Molina, L;
Nicolini, F;
Tigaud, J D;
Sotto, J-J;
Guyotat, D;
Fière, D;
Archimbaud, E

Publication type:

Article

Increases in 4-hydroxynonenal and hexanal in bone marrow of rats subjected to total body X-ray irradiation: association with antioxidant vitamins.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 173, doi. 10.1038/sj.bmt.1701531

By:

Umegaki, K;
Sano, M;
Suzuki, K;
Tomita, I;
Esashi, T

Publication type:

Article

Treatment with interleukin-2 (IL-2) and interferon (IFNalpha 2b) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 169, doi. 10.1038/sj.bmt.1701532

By:

Vivancos, P.;
Grañena, Jr., A.;
Sarrá, J.;
Grañena, A.

Publication type:

Article

Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 137, doi. 10.1038/sj.bmt.1701535

By:

Harris, D T;
Sakiestewa, D;
Lyons, C;
Kreitman, R J;
Pastan, I

Publication type:

Article

Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 195, doi. 10.1038/sj.bmt.1701546

By:

van der Griend, R;
Verdonck, L F;
Petersen, E J;
Veenhuizen, P;
Bloem, A C;
Lokhorst, H M

Publication type:

Article

Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 × 5 μg/kg) compared to a single dose (1 × 10 μg/kg).

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 125

By:

Kröger, N;
Zeller, W;
Hassan, H T;
Krüger, W;
Gutensohn, K;
Löliger, C;
Zander, A R

Publication type:

Article

Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 131, doi. 10.1038/sj.bmt.1701551

By:

Shlebak, A A;
Marley, S B;
Roberts, I A G;
Davidson, R J;
Goldman, J M;
Gordon, M Y

Publication type:

Article

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 163, doi. 10.1038/sj.bmt.1701543

By:

Kelsey, S M;
Goldman, J M;
McCann, S;
Newland, A C;
Scarffe, J H;
Oppenheim, B A;
Mufti, G J

Publication type:

Article

Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 191, doi. 10.1038/sj.bmt.1701542

By:

Gopal, A K;
Thorning, D R;
Back, A L

Publication type:

Article

Accelerated atherosclerosis in a patient with post-BMT nephropathy.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 199, doi. 10.1038/sj.bmt.1701544

By:

Akasheh, M;
Priyanath, A;
Pello, N;
Watry, P;
Vesole, D

Publication type:

Article

Image-guided central venous catheters for apheresis.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 179, doi. 10.1038/sj.bmt.1701545

By:

Sadler, D J;
Gordon, A C;
Klassen, J;
Saliken, J C;
So, C B;
Gray, R R

Publication type:

Article

Anaphylactoid reaction to granulocyte colony-stimulating factor used in mobilization of peripheral blood stem cell.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 200, doi. 10.1038/sj.bmt.1701547

By:

Keung, Y-K;
Suwanvecho, S;
Cobos, E

Publication type:

Article

Detection of maternal cell contamination in human cord blood: which perspectives?

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 200, doi. 10.1038/sj.bmt.1701548

By:

Poli, F;
Scalamogna, M;
Tettamanti, C;
Ghidoli, N;
Sirchia, G

Publication type:

Article

IL-2/LAK therapy for refractory acute monoblastic leukemia relapsing after unrelated allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 183, doi. 10.1038/sj.bmt.1701550

By:

Nagayama, H;
Takahashi, S;
Takahashi, T;
Ogami, K;
Ikebuchi, K;
Tojo, A;
Tani, K;
Asano, S

Publication type:

Article

Administration of G-CSF to normal individuals diminishes L-selectin+ T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin- T cells.

Published in:

Bone Marrow Transplantation, 1999, v. 23, n. 2, p. 119, doi. 10.1038/sj.bmt.1701552

By:

Sugimori, N;
Nakao, S;
Yachie, A;
Niki, T;
Takami, A;
Yamazaki, H;
Miura, Y;
Ueda, M;
Shiobara, S;
Matsuda, Tamotsu

Publication type:

Article

Works matching IS 02683369 AND DT 1999 AND VI 23 AND IP 2

The cytotoxicity of mafosfamide on G-CSF mobilized hematopoietic progenitors is reduced by SH groups of albumin – implications for further purging strategies.

Bruno Speck.

Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens.

Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma.

Parentage testing implications of male fertility after allogeneic bone marrow transplantation.

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.

Increases in 4-hydroxynonenal and hexanal in bone marrow of rats subjected to total body X-ray irradiation: association with antioxidant vitamins.

Treatment with interleukin-2 (IL-2) and interferon (IFN<sub>alpha 2b</sub>) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse.

Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.

Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.

Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 × 5 μg/kg) compared to a single dose (1 × 10 μg/kg).

Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation.

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings.

Accelerated atherosclerosis in a patient with post-BMT nephropathy.

Image-guided central venous catheters for apheresis.

Anaphylactoid reaction to granulocyte colony-stimulating factor used in mobilization of peripheral blood stem cell.

Detection of maternal cell contamination in human cord blood: which perspectives?

IL-2/LAK therapy for refractory acute monoblastic leukemia relapsing after unrelated allogeneic bone marrow transplantation.

Administration of G-CSF to normal individuals diminishes L-selectin<sup>+</sup> T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin<sup>-</sup> T cells.